SEC Form 4 · accession 0001140361-18-003241
Loxo Oncology, Inc. · LOXO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avi Z. Naider
Director
Period of report
Jan 22, 2018
Accepted (ET)
Jan 25, 2018 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001581720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2018 | G | 3,000 | $0.00 | D | 141,118 | D | |
| Common Stock | Jan 22, 2018 | S | 15,000 | $100.00 | D | 126,118 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.